Lioresal; 4-Amino-3-(4-chlorophenyl)butanoic acid; Baclon; DL-Baclofen; Kemstro; (+-)-Baclofen; Gabalon; 4-Amino-3-(4-chlorophenyl)butyric acid; Baclofene; Baclofeno; Baclofenum; Lioresal Intrathecal; beta-(4-Chlorophenyl)gaba; (RS)-BACLOFEN; Ciba 34,647-Ba; (+/-)-BACLOFEN; DL-4-Amino-3-p-chlorophenylbutanoic acid; beta-(Aminomethyl)-4-chlorobenzenepropanoic acid; Ba-34647; beta-(p-Chlorophenyl)-gamma-aminobutyric acid; Baclofen (R,S); C 34647Ba; Ba 34647; beta-(Aminomethyl)-p-chlorohydrocinnamic acid; gamma-Amino-beta-(p-chlorophenyl)butyric acid; Ba-34,647; Butanoic acid, 4-amino-3-(4-chlorophenyl)-; MFCD00055143; CHEMBL701; (+)-Baclofen; (L)-Baclofen; Atrofen; Baclophen; Apo-Baclofen; HYDROCINNAMIC ACID, beta-(AMINOMETHYL)-p-CHLORO-; NCGC00015156-11; (RS)-Amino-3-(4-chlorophenyl)butyric acid; DSSTox_CID_2641; 4-AMINO-3(4-CHLOROPHENYL)BUTYRIC ACID; Baclofene [INN-French]; Baclofenum [INN-Latin]; DSSTox_RID_76670; Baclofeno [INN-Spanish]; DSSTox_GSID_22641; Gablofen; Lioresal (TN); Kemstro (TN); CCRIS 3722; SR-01000000107; EINECS 214-486-9; BRN 2104494; baclofen o; IPX056; MFCD01321057; IPX 056; (y)-Baclofen; Prestwick_85; (?)-Baclofen; Baclofen [USAN:USP:INN:BAN:JAN]; (A+/-)-Baclofen; Spectrum_000066; (.+/-.)-Baclofen; (.+/-.)-Baklofen; Prestwick0_000085; Prestwick1_000085; Prestwick2_000085; Prestwick3_000085; Spectrum2_000092; Spectrum3_000310; Spectrum4_000245; Spectrum5_000852; Biomol-NT_000251; UPCMLD-DP142; ()-Baclofen; B 5399; Lopac0_000163; Oprea1_440627; SCHEMBL19333; BSPBio_000010; BSPBio_001880; KBioGR_000650; KBioSS_000466; MLS000028480; .beta.-(4-Chlorophenyl)gaba; DivK1c_000001; SPECTRUM1500135; Baclofen (JP17/USP/INN); SPBio_000044; SPBio_001949; BPBio1_000012; BPBio1_000750; GTPL1084; DTXSID5022641; UPCMLD-DP142:001; BDBM24182; CTK2F7435; HMS500A03; KBio1_000001; KBio2_000466; KBio2_003034; KBio2_005602; KBio3_001380; KS-00000VAF; AOB5950; Baclofen 0.5 mg/ml in Methanol; NINDS_000001; HMS1568A12; HMS1920E21; HMS2091M03; HMS2095A12; HMS3260B07; HMS3712A12; Pharmakon1600-01500135; 4-Amino-3-(4-chlorophenyl)butyri; ALBB-014712; BCP11844; BCP32777; EX-A1378; HY-B0007; Tox21_110090; Tox21_500163; BBL010735; CCG-38910; CX1358; NSC329137; NSC755906; s4840; STK535284; AKOS005174692; Tox21_110090_1; AC-4530; DB00181; HS-1001; LP00163; MB00475; MCULE-2275748923; NSC-329137; NSC-755906; SDCCGSBI-0050151.P005; 4-Amino-3-(p-chlorophenyl)butyric acid; IDI1_000001; SMP1_000036; NCGC00015156-04; NCGC00015156-05; NCGC00015156-06; NCGC00015156-07; NCGC00015156-08; NCGC00015156-12; NCGC00015156-13; NCGC00015156-15; NCGC00015156-26; NCGC00023843-03; NCGC00024579-03; NCGC00024579-04; NCGC00024579-05; NCGC00024579-06; NCGC00260848-01; AK109161; AK327205; SC-19053; SMR000058294; ST075584; SY023865; SY052300; SBI-0050151.P004; AB0012560; (+/-)-Baclofen, >=98% (TLC), solid; .beta.-Aminomethyl-p-chlorohydrocinnamic acid; 4-Amino-3-(4-chlorophenyl)butanoic acid #; AB00051921; EU-0100163; FT-0622547; FT-0662468; FT-0662469; (RS)-4-Amino-3-(4-chlorophenyl)butanoic acid; .beta.-(Aminomethyl)-p-chlorohydrocinnamic acid; D00241; J10366; M-2046; 4-Amino-3-(4-chlorophenyl)butyricAcid,Baclofen; AB00051921_16; .beta.-(p-Chlorophenyl)-.gamma.-aminobutyric acid; .gamma.-Amino-.beta.-(p-chlorophenyl)butyric acid; 134B470; L000002; Q413717; J-002965; SR-01000000107-2; SR-01000000107-4; SR-01000000107-6; SR-01000000107-8; BRD-A84174873-001-05-2; F2173-1127; STX209; STX-209; STX 209; D-Baclofen; Arbaclofen